发明授权
- 专利标题： Treatment of disparate bleeding disorders with factor X zymogen
- 专利标题（中）： 用因子X酶原治疗不同的出血障碍
-
申请号： US508167申请日： 1983-06-27
-
公开(公告)号： US4501731A公开(公告)日： 1985-02-26
- 发明人: Garson H. Tishkoff , Douglas W. Estry
- 申请人： Garson H. Tishkoff , Douglas W. Estry
- 专利权人： Tishkoff Garson H,Estry Douglas W
- 当前专利权人： Tishkoff Garson H,Estry Douglas W
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; C12N9/64 ; A61K35/16
摘要：
The invention provides a method for the treatment of disparate bleeding disorders comprising the administration of factor X zymogen in amounts sufficient to control pathological bleeding, and a therapeutic product based on the coagulant activity of a factor X zymogen-phospholipid-factor Va clotting system. The product is generally substantially free of activators for the factor X zymogen.
公开/授权文献
- US5102877A 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds 公开/授权日：1992-04-07
信息查询
IPC分类:
